1. Home
  2. VIAV vs NVCR Comparison

VIAV vs NVCR Comparison

Compare VIAV & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viavi Solutions Inc.

VIAV

Viavi Solutions Inc.

HOLD

Current Price

$18.08

Market Cap

4.3B

Sector

Technology

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$13.35

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIAV
NVCR
Founded
1923
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Semiconductors
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
1.3B
IPO Year
1993
2015

Fundamental Metrics

Financial Performance
Metric
VIAV
NVCR
Price
$18.08
$13.35
Analyst Decision
Buy
Buy
Analyst Count
8
6
Target Price
$16.16
$28.42
AVG Volume (30 Days)
3.9M
1.7M
Earning Date
01-29-2026
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.06
N/A
Revenue
$1,145,200,000.00
$642,269,000.00
Revenue This Year
$30.31
$9.75
Revenue Next Year
$8.78
$5.62
P/E Ratio
$295.01
N/A
Revenue Growth
15.60
11.17
52 Week Low
$8.10
$10.70
52 Week High
$19.76
$34.13

Technical Indicators

Market Signals
Indicator
VIAV
NVCR
Relative Strength Index (RSI) 56.24 60.37
Support Level $16.69 $10.79
Resistance Level $19.76 $13.94
Average True Range (ATR) 0.80 0.61
MACD 0.03 0.22
Stochastic Oscillator 54.69 80.48

Price Performance

Historical Comparison
VIAV
NVCR

About VIAV Viavi Solutions Inc.

Viavi Solutions Inc. is an international provider of network test, monitoring, and assurance solutions to communications service providers, enterprises, network equipment manufacturers, civil government, military and avionics customers. The company also offers high-performance thin-film optical coatings, providing light management solutions to anti-counterfeiting, 3D sensing, electronics, automotive, defense, and instrumentation markets. Its operating segments include Network Enablement, Service Enablement, and Optical Security and Performance Products. Geographically, it derives a majority of its revenue from the United States. Additionally, it manufactures and sells optical filters for 3D sensing products that allow facial recognition security authentication for mobile devices.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: